Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
Annexin
-
search results
If you're not happy with the results, please do another search
Investing in life science: From Seed to Success 2024
16 September, 2024
Annexin Pharmaceuticals: Could ANXV replace anti-VEGFs?
27 August, 2024
Annexin comments on acquisition and focus on ANXV in ophthalmology
28 June, 2024
Annexin’s phase II study fully recruited with positive signals
30 April, 2024
Annexin towards completion of phase II study and share issue
18 April, 2024
Strong start for Annexin in 2024
14 February, 2024
2023’s strongest and weakest life science stocks
9 January, 2024
Annexin’s CSO on progress in cancer initiative
18 October, 2023
Watch the interviews from BioStock Investor Meeting!
26 September, 2023
Watch the presentations from BioStock Investor Meeting!
22 September, 2023
Annexin’s CEO: “Our biggest success in a long time”
5 September, 2023
The BioStock Life Science Spring Summit 2023 goes live today
30 May, 2023
Annexin’s CMO on study results and participation in ARVO
12 May, 2023
One-on-one with Annexin Pharmaceuticals’ new CFO
11 April, 2023
SynAct Pharma announces change in management
3 April, 2023
Intense Q4 leads Annexin into interesting 2023
16 February, 2023
Annexin’s CEO: “The cancer area more than doubles the potential”
6 February, 2023
Annexin updates in conjunction with the Q3 report
10 November, 2022
Phase II focus and further potential in Annexin´s Q2
31 August, 2022
Annexin wants to treat the inconspicuous eye disease
6 July, 2022
Annexin´s CMO on patent strategy
19 May, 2022
Annexin receives FDA approval for phase II study
8 April, 2022
Annexin’s CEO on ANXV’s potential and the plan for 2022
1 April, 2022
Join us for the BioStock Life Science Summit on October 20...
20 October, 2021
Stayble Therapeutics elects new Chairman of the Board
3 June, 2021
